Sign in to view content

Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology

Matthew P. Ohr, MD

Video
Published 2020

Related

Interim Safety and Efficacy Results From the Phase 1 HELIOS Trial of Sustained-Release Axitinib Implant (OTX-TKI) for NPDR
Dilsher S. Dhoot, MD
Annual Meeting Talks
2024
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019
Retinal Vascular Disease Take-Home Panel
Neil M. Bressler, MD
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more